Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates

(American Society for Radiation Oncology) Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy have a 5-year survival rate of 40 percent, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th Annual Meeting.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news